BiondVax's Innovative Inhaled Anti-SARS-CoV-2 NanoAb

COVID-19 illness was virtually prevented in hamsters administered BiondVax’s inhaled NanoAb and infected three hours later with SARS-CoV-2  Data further...

Related Keywords

Wuhan ,Hubei ,China ,Jerusalem ,Israel General ,Israel ,Germany ,California ,United States ,Tamar Ben Yedidia ,Los Angeles ,Biondvax Nanoab ,Amir Reichman ,Max Planck Institute For Multidisciplinary Sciences ,Exchange Commission On ,Biondvax Pharmaceuticals Ltd ,University Medical Center ,Fraunhofer Institute For Toxicology ,University Of Veterinary Medicine Hannover Tiho ,Nasdaq ,Pfizer ,Company Annual Report On Form ,Astrazeneca ,Corporate Communications ,Biondvax Pharmaceuticals ,Chief Science Officer ,Severe Acute Respiratory Syndrome ,Fraunhofer Institute ,Experimental Medicine ,Veterinary Medicine Hannover ,Max Planck Institute ,Multidisciplinary Sciences ,Vax Pharmaceuticals ,Private Litigation Reform Act ,Annual Report ,Exchange Commission ,Nasdaq Bvxv ,Bvxv ,Biopharmaceuticals ,Nhaled Anti Sars Cov 2 ,Anoab ,Biotechnology ,Mmunotherapeutic Products ,